Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
83
Top-10 weight
50.01%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
26
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1269.0
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 78,956 | $81.89M | 12.06% |
| 2 | JOHNSON&JOHNSON | — | 203,737 | $46.30M | 6.82% |
| 3 | ABBVIE INC | — | 176,476 | $39.36M | 5.80% |
| 4 | MERCK & CO | — | 258,630 | $28.52M | 4.20% |
| 5 | GILEAD SCIENCES INC | — | 192,684 | $27.35M | 4.03% |
| 6 | STRYKER CORP | — | 72,515 | $26.80M | 3.95% |
| 7 | BOSTON SCIENTIFIC CORP | — | 258,341 | $24.16M | 3.56% |
| 8 | MEDTRONIC PLC | — | 219,885 | $22.64M | 3.33% |
| 9 | ASTRAZENECA PLC | — | 117,224 | $21.84M | 3.22% |
| 10 | Novartis AG (Registered) | NVSEF | 139,687 | $20.73M | 3.05% |
| 11 | AMGEN INC | — | 54,378 | $18.59M | 2.74% |
| 12 | UNITEDHEALTH GRP | — | 64,753 | $18.58M | 2.74% |
| 13 | GSK PLC | — | 638,908 | $16.52M | 2.43% |
| 14 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 35,909 | $16.33M | 2.41% |
| 15 | THERMO FISHER SCIENTIFIC INC | — | 27,028 | $15.64M | 2.30% |
| 16 | IQVIA HOLDINGS INC | — | 43,685 | $10.05M | 1.48% |
| 17 | MCKESSON CORP | — | 12,079 | $10.04M | 1.48% |
| 18 | THE CIGNA GROUP | — | 36,099 | $9.90M | 1.46% |
| 19 | REGENERON PHARMACEUTICALS INC | — | 11,851 | $8.79M | 1.29% |
| 20 | ABBOTT LABS | — | 76,731 | $8.39M | 1.24% |
| 21 | NOVO NORDISK-B | — | 137,807 | $8.18M | 1.21% |
| 22 | CARDINAL HEALTH INC | — | 36,256 | $7.79M | 1.15% |
| 23 | STERIS PLC | — | 29,602 | $7.77M | 1.15% |
| 24 | VERTEX PHARMACEUTICALS INC | — | 16,082 | $7.56M | 1.11% |
| 25 | BECTON DICKINSON and CO | — | 32,773 | $6.67M | 0.98% |
| 26 | EXELIXIS INC | — | 158,852 | $6.57M | 0.97% |
| 27 | RESMED INC | — | 25,092 | $6.48M | 0.95% |
| 28 | HEALTHEQUITY INC | — | 74,678 | $6.40M | 0.94% |
| 29 | ASTELLAS PHARMA | — | 454,200 | $6.32M | 0.93% |
| 30 | METTLER-TOLEDO INTL INC | — | 4,534 | $6.23M | 0.92% |
| 31 | DANAHER CORP | — | 27,687 | $6.06M | 0.89% |
| 32 | HCA HEALTHCARE INC | — | 11,889 | $5.81M | 0.86% |
| 33 | UCB SA | — | 17,540 | $5.34M | 0.79% |
| 34 | UNITED THERAPEUTICS CORP DEL | — | 11,322 | $5.32M | 0.78% |
| 35 | IPSEN | — | 30,215 | $4.94M | 0.73% |
| 36 | BIOGEN INC | — | 27,139 | $4.88M | 0.72% |
| 37 | PRESTIGE CONSUMER HEALTHCARE INC | — | 75,168 | $4.85M | 0.71% |
| 38 | MEDPACE HOLDINGS INC | — | 8,307 | $4.84M | 0.71% |
| 39 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 59,078 | $4.67M | 0.69% |
| 40 | ANI PHARMACEUTICALS INC | — | 56,156 | $4.60M | 0.68% |
| 41 | BRISTOL-MYERS SQUIBB CO | — | 70,915 | $3.90M | 0.58% |
| 42 | VERACYTE INC | — | 94,965 | $3.62M | 0.53% |
| 43 | INTUITIVE SURGICAL INC | — | 7,152 | $3.61M | 0.53% |
| 44 | INCYTE CORP | — | 33,385 | $3.34M | 0.49% |
| 45 | Sanofi SA | — | 35,093 | $3.31M | 0.49% |
| 46 | CATALYST PHARMACEUTICALS INC | — | 133,424 | $3.24M | 0.48% |
| 47 | BRIGHTSPRING HEALTH SERVICES INC | — | 78,481 | $3.08M | 0.45% |
| 48 | SHIONOGI & CO | — | 146,000 | $3.01M | 0.44% |
| 49 | HANSOH PHARMACEU | — | 600,000 | $2.96M | 0.44% |
| 50 | AGILENT TECHNOLOGIES INC | — | 20,814 | $2.79M | 0.41% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.